Evernest Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
3,684
-92
-2% -$31.5K 0.28% 56
2026
Q1
$1.28M Buy
3,776
+172
+5% +$61.3K 0.27% 57
2025
Q4
$1.35M Buy
3,604
+236
+7% +$74.9K 0.28% 54
2025
Q3
$950K Buy
3,368
+49
+1% +$14.2K 0.27% 76
2025
Q2
$927K Buy
3,319
+319
+11% +$90.4K 0.3% 71
2025
Q1
$935K Buy
3,000
+275
+10% +$81.2K 0.34% 69
2024
Q4
$710K Buy
2,725
+62
+2% +$18.4K 0.18% 90
2024
Q3
$858K Buy
2,663
+99
+4% +$32.4K 0.23% 72
2024
Q2
$801K Sell
2,564
-154
-6% -$45.2K 0.36% 62
2024
Q1
$731K Buy
2,718
+106
+4% +$31K 0.35% 62
2023
Q4
$752K Buy
+2,612
New +$712K 0.38% 64
2021
Q4
$768K Buy
+2,638
New +$557K 0.4% 58

Other funds holding AMGN

Evernest Financial Advisors's AMGN Position: Q2 2026 in Review

Evernest Financial Advisors reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $31.5K and leaving 3,684 shares worth $1.33M. The position accounts for 0.28% of the portfolio, ranked #56.

Evernest Financial Advisors first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.35M in Q4 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Evernest Financial Advisors held 3,684 shares of Amgen worth $1.33M as of Q2 2026.
  • Evernest Financial Advisors sold 92 Amgen shares in Q2 2026, an estimated $31.5K.
  • Amgen made up 0.28% of Evernest Financial Advisors's portfolio in Q2 2026, its #56 holding.
  • Evernest Financial Advisors first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • Evernest Financial Advisors's Amgen position peaked at $1.35M in Q4 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.